Sandbox Yaz: Difference between revisions

Jump to navigation Jump to search
YazanDaaboul (talk | contribs)
No edit summary
YazanDaaboul (talk | contribs)
No edit summary
Line 37: Line 37:
::❑ Dopamine 5 microgram/kg/minute; titrate by 5 microgram/kg/minute every 10 minutes
::❑ Dopamine 5 microgram/kg/minute; titrate by 5 microgram/kg/minute every 10 minutes
❑ Obtain 12 lead ECG and place the patient on a cardiac monitor <br>
❑ Obtain 12 lead ECG and place the patient on a cardiac monitor <br>
❑ Place an indwelling urethral catheter and monitor urine output  qFrequently assess mental status and check for focal neurologic deficits qInitial laboratory work-up<br>
❑ Place an indwelling urethral catheter and monitor urine output  qFrequently assess mental status and check for focal neurologic deficits qInitial laboratory work-up<br>
❑ Type and crossmatch 6 to 10 units of PRBC. FFP may also be needed in cases of massive transfusion<br>
❑ Type and crossmatch 6 to 10 units of PRBC. FFP may also be needed in cases of massive transfusion<br>
Line 53: Line 52:
{{familytree | | | | | | | |!| | | | | | | | | | | }}
{{familytree | | | | | | | |!| | | | | | | | | | | }}
{{familytree | | | | | | | C01 | | | | | | | | | | C01=Patient hemodynamically unstable despite resuscitation?<br>
{{familytree | | | | | | | C01 | | | | | | | | | | C01=Patient hemodynamically unstable despite resuscitation?<br>
❑ Hypotension (SBP < 90 mm Hg) despite resuscitation
❑ Hypotension (SBP < 90 mm Hg) despite resuscitation
❑ Tachycardia (HR > 100 bpm) despite resuscitation }}
❑ Tachycardia (HR > 100 bpm) despite resuscitation }}
{{familytree | | | |,|-|-|-|^|-|-|-|.| | | | | | | }}
{{familytree | | | |,|-|-|-|^|-|-|-|.| | | | | | | }}
Line 65: Line 62:
{{familytree | |!| | | |!| | | |!| | | |!| | | | | }}
{{familytree | |!| | | |!| | | |!| | | |!| | | | | }}
{{familytree | G01 | | G02 | | G03 | | G04 | | | | G01=❑ Proceed to operating room without further work-up| G02=❑ Obtain focused bedside ultrasound | G03=❑ Obtain CT scan <u>with</u> IV contrast of abdominal aorta and iliac arteries | G04=❑ Obtain CT scan <u>without</u> IV contrast of abdominal aorta and iliac arteries}}
{{familytree | G01 | | G02 | | G03 | | G04 | | | | G01=❑ Proceed to operating room without further work-up| G02=❑ Obtain focused bedside ultrasound | G03=❑ Obtain CT scan <u>with</u> IV contrast of abdominal aorta and iliac arteries | G04=❑ Obtain CT scan <u>without</u> IV contrast of abdominal aorta and iliac arteries}}
{{familytree | | | | | |`|-|-|-|+|-|-|-|'| | | | | }}
{{familytree | | | | | |`|-|-|-|+|-|-|-|'| | | | | }}
{{familytree | | | | | | | | | H01 | | | | | | | | H01=AAA confirmed on imaging?}}
{{familytree | | | | | | | | | H01 | | | | | | | | H01=AAA confirmed on imaging?}}
Line 74: Line 70:
'''Evaluate need for further management of the following AAA complications'''
'''Evaluate need for further management of the following AAA complications'''
'''For patients suspected to have thromboembolism'''<br>
'''For patients suspected to have thromboembolism'''<br>
❑ Obtain Duplex ultrasound of affected extremities<br>
❑ Obtain Duplex ultrasound of affected extremities<br>
❑ Consider CT scan of aorta from aortic valves to iliac bifurcation<br><br>
❑ Consider CT scan of aorta from aortic valves to iliac bifurcation<br><br>
'''For patients suspected to have infected (mycotic) aneurysm'''<br>
'''For patients suspected to have infected (mycotic) aneurysm'''<br>
  ❑ Consider gallium scanning or 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) to evaluate disease activity<br><br>
  ❑ Consider gallium scanning or 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) to evaluate disease activity<br><br>
'''For patients suspected to have aortovenous fistula'''<br>
'''For patients suspected to have aortovenous fistula'''<br>
❑ Obtain CT angiography<br><br>
❑ Obtain CT angiography<br><br>
'''For patients suspected to have aortoenteric fistula'''<br>
'''For patients suspected to have aortoenteric fistula'''<br>
❑ Perform EGD to rule out other possible etiologies  of GI bleed among hemodynamically stable patients<br>
❑ Perform EGD to rule out other possible etiologies  of GI bleed among hemodynamically stable patients<br>
Line 96: Line 83:
{{familytree | | | | | | | K01 | | | | | | | | | | K01=Once diagnosis of complicated AAA is confirmed, all patients require blood cultures and empirical antibiotic therapy for gram-positive and gram-negative coverage (even if afebrile at presentation)<br>
{{familytree | | | | | | | K01 | | | | | | | | | | K01=Once diagnosis of complicated AAA is confirmed, all patients require blood cultures and empirical antibiotic therapy for gram-positive and gram-negative coverage (even if afebrile at presentation)<br>
❑ Withdraw multiple sets of blood culture (if blood cultures were not withdrawn initially)<br>
❑ Withdraw multiple sets of blood culture (if blood cultures were not withdrawn initially)<br>
❑ Administer empiric combination antibiotic therapy <br>
❑ Administer empiric combination antibiotic therapy <br>
:❑ Vancomycin 1-1.5g IV every 12 hours
:❑ Vancomycin 1-1.5g IV every 12 hours
Line 102: Line 88:
::One of the following
::One of the following
:❑ Ceftriaxone 2 g IV every 12  hours, '''OR'''  
:❑ Ceftriaxone 2 g IV every 12  hours, '''OR'''  
:❑ Cefuroxime 1.5 g IV every 4 hours, '''OR'''
:❑ Cefuroxime 1.5 g IV every 4 hours, '''OR'''
:❑ Piperacillin-tazobactam  
:❑ Piperacillin-tazobactam  
}}
}}
{{familytree | | | | | | | |!| | | | | | | | | | | }}
{{familytree | | | | | | | |!| | | | | | | | | | | }}
{{familytree | | | | | | | L01 | | | | | | | | | | L01=Proceed to further management}}
{{familytree | | | | | | | L01 | | | | | | | | | | L01=Proceed to further management}}
{{familytree/end}}
{{familytree/end}}

Revision as of 17:20, 7 April 2015

 
 
 
 
 
 
Identify cardinal findings that increase the pre-test probability of symptomatic or complicated abdominal aortic aneurysm (AAA)

❑ Known large AAA > 5.5 cm or known rapid AAA expansion rate > 0.5 cm/year
❑ Acute abdominal/back pain that may radiate to buttocks, groin region, or lower extremities

❑ Tearing/sharp quality
❑ Increasing in intensity

❑ Pulsating abdominal mass
❑ Hypotension or shock
❑ Altered mental status
❑ Unexplained syncope
❑ Coma
❑ Muscular weakness
❑ Cold extremities
❑ Peripheral cyanosis
❑ Acute limb pain
❑ Fever or sepsis
❑ Known infective endocarditis (high risk for infected aneurysm)
❑ Presence of AAA risk factors

❑ Female gender
❑ Advanced age > 50 years
❑ Smoking
❑ Advanced atherosclerosis
❑ History of prior stroke
❑ Hypertension
❑ Transplantation (Cardiac or renal)
❑ Known reduced FEV1 (obstructive pulmonary disease)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stabilize and resuscitate the patient

❑ Attend to the patient's ABCs (Airway, Breathing, Circulation)

❑ Consider endotracheal intubation if the patient's airway is compromised, has a Glasgow coma scale (GCS < 8) or profound hemodynamic instability
❑ Administer oxygen and maintain a saturation >90%
❑ Secure 2 large-bore intravenous (IV) lines
❑ Administer fluids to reach a target systolic blood pressure (SBP) of 70 to 100 mm Hg. Excessive fluid administration in AAA is associated with worse outcomes
❑ Do NOT routinely administer vasopressors if patient is hypotensive at presentation. Vasopressor administration in AAA is controversial. Consider ANY of the following vasopressors only if patient remains hypotensive despite fluids
❑ Norepinephrine 0.05 microgram/kg/minute IV; titrate by 0.02 microgram/kg/minute every 5 minutes, OR
❑ Phenylephrine 100-180 microgram/minute; titrate by 25 microgram/minute every 10 minutes, OR
❑ Dopamine 5 microgram/kg/minute; titrate by 5 microgram/kg/minute every 10 minutes

❑ Obtain 12 lead ECG and place the patient on a cardiac monitor
❑ Place an indwelling urethral catheter and monitor urine output qFrequently assess mental status and check for focal neurologic deficits qInitial laboratory work-up
❑ Type and crossmatch 6 to 10 units of PRBC. FFP may also be needed in cases of massive transfusion

❑ Do not administer pre-op transfusions except if patient is unconscious or has signs or myocardial infarction

❑ Withdraw blood for CBC, electrolytes, BUN, serum creatinine, LFTS, PT, PTT, troponin I, CK, CK-MB, CRP or ESR, and multiple blood cultures
Pain management ❑ Assess pain severity (self-report NRS scale 0 to 10; unconscious BPS 3-12 or CPOT 0-8). Pain considered significant if NRS≥4, BPS<5, or CPOT≥3
❑ Administer IV opioids: Morphine 4-10 mg IV every 4 hours, infused over 4-5 minutes (dose range: 5-15 mg)
❑ Consider pre-op epidural catheter if patient meets ALL of the following criteria

❑ Patient hemodynamically stable, AND
❑ Contained leak, AND
❑ Satisfactory coagulation profile

❑ Maintain patient in a conscious state

❑ Monitor any significant undesired drop in blood pressure as pain medications are administered
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient hemodynamically unstable despite resuscitation?

❑ Hypotension (SBP < 90 mm Hg) despite resuscitation

❑ Tachycardia (HR > 100 bpm) despite resuscitation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes. Patient is still hemodynamically unstable despite resuscitation.
 
 
 
 
 
No. Patient is hemodynamically stable following resuscitation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Is the patient known to have an AAA?
 
 
 
 
 
Can patient have CT scan with contrast?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
No
 
Yes
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Proceed to operating room without further work-up
 
❑ Obtain focused bedside ultrasound
 
❑ Obtain CT scan with IV contrast of abdominal aorta and iliac arteries
 
❑ Obtain CT scan without IV contrast of abdominal aorta and iliac arteries
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AAA confirmed on imaging?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evaluate need for further management of the following AAA complications

For patients suspected to have thromboembolism
❑ Obtain Duplex ultrasound of affected extremities
❑ Consider CT scan of aorta from aortic valves to iliac bifurcation

For patients suspected to have infected (mycotic) aneurysm

❑ Consider gallium scanning or 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) to evaluate disease activity

For patients suspected to have aortovenous fistula
❑ Obtain CT angiography

For patients suspected to have aortoenteric fistula
❑ Perform EGD to rule out other possible etiologies of GI bleed among hemodynamically stable patients
❑ Obtain CT scan with IV contrast of the abdomen and iliac arteries

❑ Consider arteriography
 
Consider alternative diagnoses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Once diagnosis of complicated AAA is confirmed, all patients require blood cultures and empirical antibiotic therapy for gram-positive and gram-negative coverage (even if afebrile at presentation)

❑ Withdraw multiple sets of blood culture (if blood cultures were not withdrawn initially)
❑ Administer empiric combination antibiotic therapy

❑ Vancomycin 1-1.5g IV every 12 hours

PLUS

One of the following
❑ Ceftriaxone 2 g IV every 12 hours, OR
❑ Cefuroxime 1.5 g IV every 4 hours, OR
❑ Piperacillin-tazobactam
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Proceed to further management